510(k) K222638

Xpert® Xpress GBS, GeneXpert® Dx System, GeneXpert® Infinity Systems by Cepheid — Product Code NJR

K222638 is an FDA 510(k) premarket notification submitted by Cepheid for the device "Xpert® Xpress GBS, GeneXpert® Dx System, GeneXpert® Infinity Systems". The FDA issued a decision of Substantially Equivalent on September 27, 2023. The device falls under product code NJR (Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test), a Class I device regulated under 21 CFR 866.3740. Cepheid has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
September 27, 2023
Date Received
September 1, 2022
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test
Device Class
Class I
Regulation Number
866.3740
Review Panel
MI
Submission Type

A nucleic acid amplification assay system (including probes, other reagents, and instrumentation) is an aid in the identification of group b streptococci from pre-partum and intra-partum women to establish colonization status.